Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina

Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina

Abstract There are no data in Argentina on the response rates to first-line treatment of classical Hodgkin Lymphoma (cHL) outside clinical trials. A total of 498 patients from 7 public and private hospitals in Argentina were retrospectively examined. The median follow-up was 37.4 months (CI 95% 17.7...

Full description

Bibliographic Details
Main Authors: Carolina Mahuad, Otero Victoria, Korin Laura, Martinez Enriqueta, Warley Fernando, García Rivello Hernán, Cristaldo Nancy, Kohan Dana, Zerga Marta, Garate Gonzalo, Vicente Repáraz María de los Ángeles, Aizpurua Florencia, Rojas Bilbao Erica, Cerana Susana, Funes Maria Eugenia, Plaza Iliana, Foncuberta Cecilia, Vijnovich Baron Anahí, Cranco Santiago, Vitriu Adriana, Gomez Mariela, Lavalle Justina, Casali Claudia, Clavijo Manuela, Melillo Luciana, Cabral Lorenzo Maria Cecilia, Miroli Augusto, Fischman Laura, Pavlove Maximiliano, Miodosky Marcela, Cugliari Silvana
Format: Article
Language:English
Published: SAABRON PRESS 2022-06-01
Series:Clinical Hematology International
Subjects:
Hodgkin disease
Survival
Real world evidence
Toxicity
Pet-adapted
Online Access:https://doi.org/10.1007/s44228-022-00008-4

Internet

https://doi.org/10.1007/s44228-022-00008-4

Similar Items